Navigation Links
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Date:3/2/2010

scription of historical facts are forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements.  These statements are based on the Company's current beliefs and expectations.  These forward-looking statements include statements regarding the potential for, and timing of, filing an NDA for Contrave.  The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved.  Actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: additional analyses of data from the Contrave Phase 3 trials and any other clinical trials of Contrave may produce negative or inconclusive results, or may be inconsistent with previously announced results or previously conducted clinical trials; the FDA may not agree with the Company's interpretation of efficacy and safety results; the FDA may require Orexigen to complete additional clinical, non-clinical or other requirements prior to the submission or the approval of NDA for Contrave; the third parties on whom Orexigen relies to assist with the development programs for Contrave, including clinical investigators, contract laboratories, clinical research organizations and manufacturing organizations, may not successfully carry out their contractual duties or obligations or meet expected deadlines, and the quality or accuracy of the data or materials generated by such third parties may be of insufficient quality to include in the Company's regulatory submissions; and other risks described in the Company's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date her
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 25, 2014  At the American Dental Association,s ... this October, KaVo Kerr Group was honored to be ... attendees the opportunity to see and test the Best ... leaders deliver lectures on the latest developments in dental ... the new DEXIS CariVu Caries Detection Device and Kerr ...
(Date:11/26/2014)... , Nov. 25, 2014   Heska Corporation (NASDAQ: ... the "Company"), a provider of advanced veterinary diagnostic and ... Grieve , Executive Chair, will attend The Benchmark Company, LLC,s ... one-on-one conference will be held at The Palmer House Hilton, ... from 8 a.m. to 2:30 p.m. Please email hska@haydenir.com ...
(Date:11/26/2014)... 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... presentations at two upcoming investor conferences.  , 31 ... on Tuesday, December 2, 2014 at 6:45 a.m. EST / ... head of EUSA International, will provide an overview of the company ... Annual Piper Jaffray Healthcare Conference in New York, NY ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
... Within3 announced that Brian Catlett has joined the ... Officer. He will be a key member of Within3,s ... that is the leading provider of online community solutions ... comes to Within3 with more than 25 years of ...
... organiser UBM Live , a division of UBM Plc ... Worldwide and collocated events will be hosted in Madrid, Spain ... contract and outsourced services and logistics, P-MEC for pharmaceutical technology ... InnoPack for pharmaceutical packaging needs. The events will run from ...
Cached Medicine Technology:Within3 Adds Chief Financial Officer 2CPhI Worldwide, ICSE, P-MEC and InnoPack Announce 2012 Events Location 2CPhI Worldwide, ICSE, P-MEC and InnoPack Announce 2012 Events Location 3
(Date:11/27/2014)... November 27, 2014 An inventor from ... embarrassing fact of life, and she wants to lessen ... minutes later, I decided that there needed to be ... said. , Easy to use and producible in design ... a woman’s private areas throughout the day. It avoids ...
(Date:11/27/2014)... WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- Most babies ... a cold, the U.S. Food and Drug Administration says. ... be given to children younger than 2 because they ... agency warned. American adults average about three colds ... children get a cold, parents might want to give ...
(Date:11/27/2014)... 27, 2014 The founders of VIM & ... and high functioning compression socks, are proud to announce the ... an innovative Gradient Pressure (TM) knitting technology that is designed ... & VIGR’s commitment to adding flair and style to a ... recently caught the eye of a writer at The ...
(Date:11/27/2014)... 2014 Two international trainers and lecturers ... will help one person with significant needs but limited ... and Dr. Mamaly Reshad of the Anacapa Dental Art ... a website devoted to helping dentist learn about using ... would be devoted to helping a patient who has ...
(Date:11/27/2014)... California (PRWEB) November 27, 2014 Developers and ... a new plugin entitled ProPip, taking FCPX to the next ... picture effect with a few clicks of a mouse,” said ... time saver that our users will appreciate.” , With ProPip ... customization leaving the possibilities truly endless. ProPip is great for ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3
... Charity Event to benefit Breast Cancer ResearchFORT LAUDERDALE, Fla., ... are invited to join Ladies Sail for a Cure, ... to raise money for the Florida Breast Cancer Coalition ... charity sailing event organized by eBoatCharters.com. The sailing catamaran, ...
... Jan. 22 Cardica, Inc.,(Nasdaq: CRDC ) today ... quarter ended December 31, 2008, on Thursday, January 29, 2009,after ... at,4:30 p.m. Eastern Time to discuss the financial results and ... Conference Call Details , To ...
... Life (AUL) today released its sixth annual ranking of ... and South Dakota top the ranking, while California, Hawaii, ... progress we are making each year toward a more ... CEO. "There is every reason for optimism even ...
... to surgery and prescription drugsSANTA FE, N.M., Jan. 22 ... currently suffer from TMJ, the grueling jaw pain and ... explain the overwhelming response to a recent article in ... treated her TMJ with Natural TMJ Relief. After the ...
... thyroid-blocking potassium iodide for nuclear radiation emergenciesMOORESVILLE, N.C., ... of 180,000 units (5.4 million doses) of ThyroShield(TM) ... Worth approximately $1.4 million, the sale was brokered ... protecting its citizens during a nuclear radiation emergency."This ...
... Calif., Jan. 22 Forterus Healthcare, a division of ... it has acquired Solutions 4 Recovery, a Dana Point, ... to close Feb. 1 2009Forterus Healthcare will operate Solutions ... Inc. Solutions 4 Recovery is the second behavioral health ...
Cached Medicine News:Health News:Ladies Set Sail to Raise Money for a Cure 2Health News:Cardica to Announce Fiscal 2009 Second Quarter Financial Results on Thursday, January 29, 2009 2Health News:Pennsylvania Most Pro-Life State in America, California Least, According to Americans United for Life State Rankings 2Health News:Natural TMJ Relief(R) Gains Momentum in the Medical Marketplace 2Health News:Kuwait Purchases 5.4 Million Doses of Emergency Nuclear Radiation Drug from Nukepills.com 2Health News:Forterus Healthcare to Acquire Solutions 4 Recovery 2
... SureFlex™ line of reusable and autoclavable Lithotripsy ... This revolutionary and patented termination method accepts ... In the unlikely event you do manage ... face absolutely prevents damage to your laser ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
Medicine Products: